Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Controlled Trial of Retransfusion of Intra-operatively Collected Filtered Whole Blood in Total Hip Surgery

NCT00822588 is registered in ClinicalTrials.gov with Wellspect HealthCare as lead sponsor.

NCT NCT00822588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00822588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Controlled Trial of Retransfusion of Intra-operatively Collected Filtered Whole Blood in Total Hip Surgery
Lead sponsor
Wellspect HealthCare
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2009
Completion date
June 30, 2010
Enrollment
227 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

arthroplasty, replacement, hip, blood transfusion, blood transfusion, autologous